Subsidiary of Fuan Pharmaceutical (300194.SZ) receives registration certificate for Zolmitriptan Hydrochloride Tablets.
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical") recently received the drug registration certificate for Quetiapine Hydrochloride Tablets issued by the National Medical Products Administration. Quetiapine hydrochloride tablets are used to treat depression and are effective for patients with or without anxiety.
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical"), recently received the drug registration certificate for Quetiapine hydrochloride tablets issued by the National Medical Products Administration. Quetiapine hydrochloride tablets are used for the treatment of depression and are effective for patients with or without anxiety.
Related Articles
MING YUAN CLOUD (00909) spent HKD 7.78 million to repurchase 2.5 million shares on December 22nd.
Citigroup: North American software sector stable growth, next leader emerges driven by AI
On December 22, MICROTECH MED-B (02235) spent HKD 94,100 to repurchase 12,200 shares.
MING YUAN CLOUD (00909) spent HKD 7.78 million to repurchase 2.5 million shares on December 22nd.
Citigroup: North American software sector stable growth, next leader emerges driven by AI
On December 22, MICROTECH MED-B (02235) spent HKD 94,100 to repurchase 12,200 shares.
